Document
IPR2017-01434, No. 2023-53 Exhibit - Ex2023 USP 5977173 (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2023-53 Exhibit - Ex2023 USP 5977173 (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2044-74 Exhibit - Ex2044 Tapros Medication Guide (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2044-74 Exhibit - Ex2044 Tapros Medication Guide (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2032-62 Exhibit - Ex2032 Zioptan Label (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2032-62 Exhibit - Ex2032 Zioptan Label (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2046-76 Exhibit - Ex2046 Sandoz Complaint (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2046-76 Exhibit - Ex2046 Sandoz Complaint (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2028-58 Exhibit - Ex2028 Supplemental Macdonald Declaration (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2028-58 Exhibit - Ex2028 Supplemental Macdonald Declaration (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 1029-51 Exhibit - Exhibit 1029 New Version of Exhibit 1006 with Certified Translation (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2017-01434, No. 1029-51 Exhibit - Exhibit 1029 New Version of Exhibit 1006 with Certified Translation (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2016-44 Exhibit - Ex 2016 Camras 1996 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2016-44 Exhibit - Ex 2016 Camras 1996 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2013-41 Exhibit - Ex 2013 Villumsen 1989 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2013-41 Exhibit - Ex 2013 Villumsen 1989 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2008-36 Exhibit - Ex 2008 Konturek 1986 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2008-36 Exhibit - Ex 2008 Konturek 1986 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2010-38 Exhibit - Ex 2010 Collins 1993 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2010-38 Exhibit - Ex 2010 Collins 1993 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2020-48 Exhibit - Ex 2020 Schoenwald 1978 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2020-48 Exhibit - Ex 2020 Schoenwald 1978 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2007-35 Exhibit - Ex 2007 Coleman 1994 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2007-35 Exhibit - Ex 2007 Coleman 1994 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2018-46 Exhibit - Ex 2018 Qiu 2015 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2018-46 Exhibit - Ex 2018 Qiu 2015 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 1008-8 Exhibit - Exhibit 1008 Bezuglov, Vladimir V ¿¿¿Fluorodeoxy Prostaglandins, Synthesis and Perspectives (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01434, No. 1008-8 Exhibit - Exhibit 1008 Bezuglov, Vladimir V ¿¿¿Fluorodeoxy Prostaglandins, Synthesis and Perspectives (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01434, No. 1010-10 Exhibit - Exhibit 1010 Stjernschantz, JW ¿¿¿From PGF2 Isopropyl Ester to Latanoprost A Review of the Development of Xalatan (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01434, No. 1010-10 Exhibit - Exhibit 1010 Stjernschantz, JW ¿¿¿From PGF2 Isopropyl Ester to Latanoprost A Review of the Development of Xalatan (P.T.A.B. May. 12, 2017)
+ More Snippets